Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control

European Spine Journal

Volumn 24, Issue 5, 2015, Pages 963-967

  Kamiya, Koshiro ^a   Koda, Masao ^a   Furuya, Takeo ^a   Kato, Kei ^a   Takahashi, Hiroshi ^b   Sakuma, Tsuyoshi ^c   Inada, Taigo ^a   Ota, Mitsutoshi ^a   Maki, Satoshi ^a   Okawa, Akihiko ^a   Ito, Yasuo ^d   Takahashi, Kazuhisa ^a   Yamazaki, Masashi ^e  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^c Seirei Sakura Citizen Hospital   (Japan)

^d Japanese Red Cross Kobe Hospital   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Clinical trial; G CSF; High dose methylprednisolone; Neuroprotective therapy; Spinal cord injury

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONVALESCENCE; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SPINAL CORD INJURIES; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; METHYLPREDNISOLONE HEMISUCCINATE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939254399     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-014-3373-0     Document Type: Article

References (16)

1. Bauchet L, Lonjon N, Perrin FE et al (2009) Strategies for spinal cord repair after injury: a review of the literature and information. Ann Phys Rehabil Med 52:330–351
2. Park E, Velumian A, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754–774
3. Varma AK, Das A, Wallace G 4th et al (2013) Spinal Cord Injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res 38:895–905
4. Bracken MB, Shepard MJ, Collins WF et al (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the second national acute spinal cord injury study. N Engl J Med 322:1405–1411
5. Bracken MB (2012) Steroids for acute spinal cord injury. Cochrane Database Syst Rev. doi:10.1002/14651858
6. Hurlbert RJ, Hadley MN, Walters BC et al (2013) Pharmacological therapy for acute spinal cord injury. Neurosurgery 72(Suppl 2):93–105. doi:10.1227/NEU.0b013e31827765c6
7. Nicola NA, Metcalf D, Matsumoto M et al (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258:9017–9023
8. Roberts AW (2005) G-CSF: a key regulator of neutrophil production, but that’s no all! Growth Factors 23:33–41
9. Kawabe J, Koda M, Hashimoto M et al (2011) Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats. J Neurosurg Spine 15:414–421. doi:10.3171/2011.5.SPINE10421
10. Koda M, Nishio Y, Kamada T et al (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 1149:223–231
11. Nishio Y, Koda M, Kamada T et al (2007) Granulocyte colony-stimulating factor (G-CSF) attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 66:724–731
12. Kadota R, Koda M, Kawabe J et al (2012) Granulocyte Colony-Stimulating Factor (G-CSF) Protects Oligpdendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLoS One 7:e50391. doi:10.1371/journal.pone.0050391
13. Takahashi H, Yamazaki M, Okawa A et al (2012) Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial. Eur Spine J 21:2580–2587. doi:10.1007/s00586-012-2213-3
14. Kliesch WF, Cruse JM, Lewis RE et al (1996) Restoration of depressed immune function in spinal cord injury patients receiving rehabilitation therapy. Paraplegia 34:82–90
15. Jackson AB, Groomes TE (1994) Incidence of respiratory complications following spinal cord injury. Arch Phys Med Rehabil 75:270–275
16. Matsumoto T, Tamaki T, Kawakami M et al (2001) Early complications of high-dose methyl-prednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 26:426–430